Literature DB >> 23402418

Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

Yingjie Wei1, Baojian Wu, Wen Jiang, Taijun Yin, Xiaobin Jia, Sumit Basu, Guangyi Yang, Ming Hu.   

Abstract

Cellular production of flavonoid glucuronides requires the action of both UDP-glucuronosyltransferases (UGT) and efflux transporters since glucuronides are too hydrophilic to diffuse across the cellular membrane. We determined the kinetics of efflux of 13 flavonoid glucuronides using the newly developed HeLa-UGT1A9 cells and correlated them with kinetic parameters derived using expressed UGT1A9. The results indicated that, among the seven monohydroxylflavones (HFs), there was moderately good correlation (r(2) ≥ 0.65) between the fraction metabolized (fmet) derived from HeLa-UGT1A9 cells and CLint derived from the UGT1A9-mediated metabolism. However, there was weak or no correlation between these two parameters for six dihydroxylflavones (DHFs). Furthermore, there was weak or no correlation between various kinetic parameters (Km, Vmax, or CLint) for the efflux and the metabolism regardless of whether we were using seven HFs, six DHFs, or a combination thereof. Instead, the cellular excretion of many flavonoid glucuronides appears to be controlled by the efflux transporter, and the poor affinity of glucuronide to the efflux transporter resulted in major intracellular accumulation of glucuronides to a level that is above the dosing concentration of its aglycone. Hence, the efflux transporters appear to act as the "Revolving Door" to control the cellular excretion of glucuronides. In conclusion, the determination of a flavonoid's susceptibility to glucuronidation must be based on both its susceptibility to glucuronidation by the enzyme and resulting glucuronide's affinity to the relevant efflux transporters, which act as the "Revolving Door(s)" to facilitate or control its removal from the cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402418      PMCID: PMC4030725          DOI: 10.1021/mp300562q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  37 in total

Review 1.  Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?

Authors:  Virendra Singh; Devendra Parmar; Mahendra Pratap Singh
Journal:  Cancer Invest       Date:  2008-10       Impact factor: 2.176

Review 2.  UGT genomic diversity: beyond gene duplication.

Authors:  Chantal Guillemette; Eric Lévesque; Mario Harvey; Judith Bellemare; Vincent Menard
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

3.  Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties.

Authors:  Stephen W J Wang; Jun Chen; Xiaobin Jia; Vincent H Tam; Ming Hu
Journal:  Drug Metab Dispos       Date:  2006-08-01       Impact factor: 3.922

4.  Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.

Authors:  Maciej J Zamek-Gliszczynski; Ken-ichi Nezasa; Xianbin Tian; Arlene S Bridges; Kun Lee; Martin G Belinsky; Gary D Kruh; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2006-09-20       Impact factor: 4.030

Review 5.  UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor-inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors.

Authors:  Karl W Bock; Barbara S Bock-Hennig
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

6.  Functional characterization of multidrug resistance-associated protein 3 (mrp3/abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine.

Authors:  Yoshiaki Kitamura; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2009-11-04       Impact factor: 4.030

Review 7.  Drug-drug interactions of silymarin on the perspective of pharmacokinetics.

Authors:  Jhy-Wen Wu; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  J Ethnopharmacol       Date:  2008-11-08       Impact factor: 4.360

Review 8.  Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

Authors:  Jiansong Yang; Mingxiang Liao; Magang Shou; Masoud Jamei; Karen Rowland Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Curr Drug Metab       Date:  2008-06       Impact factor: 3.731

9.  Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.

Authors:  Shingo Sakamoto; Hiroyuki Kusuhara; Kazutoshi Horie; Kohji Takahashi; Takahiko Baba; Jun Ishizaki; Yuichi Sugiyama
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

10.  Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones.

Authors:  Lan Tang; Rashim Singh; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

View more
  6 in total

1.  Blood-Placental Barrier Transfers and Pharmacokinetics of Unbound Morphine in Pregnant Rats with Multiple Microdialysis Systems.

Authors:  I-Hsin Lin; Ling Yang; Thomas Y Hsueh; Tung-Hu Tsai
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-30

2.  Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids.

Authors:  Peimin Dai; Lijun Zhu; Feifei Luo; Linlin Lu; Qiang Li; Liping Wang; Ying Wang; Xinchun Wang; Ming Hu; Zhongqiu Liu
Journal:  AAPS J       Date:  2015-03-12       Impact factor: 4.009

3.  Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

Authors:  Shufan Ge; Yifan Tu; Ming Hu
Journal:  Curr Pharmacol Rep       Date:  2016-11-08

4.  Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.

Authors:  Meifang Wang; Guangyi Yang; Yu He; Beibei Xu; Min Zeng; Shufan Ge; Taijun Yin; Song Gao; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-07-06       Impact factor: 5.914

5.  Functionalised Mn(VI)-nanoparticles: an advanced high-valent magnetic catalyst.

Authors:  Saikat Khamarui; Yasmin Saima; Radha M Laha; Subhadeep Ghosh; Dilip K Maiti
Journal:  Sci Rep       Date:  2015-03-02       Impact factor: 4.379

6.  Matrix Effects of the Hydroethanolic Extract of Calyces of Physalis peruviana L. on Rutin Pharmacokinetics in Wistar Rats Using Population Modeling.

Authors:  Gina Paola Domínguez Moré; María Isabel Cardona; Paula Michelle Sepúlveda; Sandra Milena Echeverry; Cláudia Maria Oliveira Simões; Diana Marcela Aragón
Journal:  Pharmaceutics       Date:  2021-04-12       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.